ERYTHROCIN Film coated tablets Ref.[6822] Active ingredients: Erythromycin

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK

Product name and form

Erythrocin 250.

Erythromycin Stearate BP 250mg.

Pharmaceutical Form
Film coated tablet.

Qualitative and quantitative composition

Active: Erythromycin as erythromycin stearate 250 mg/tablet.

Active Ingredient	Description
Erythromycin	Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.

List of Excipients
Povidone Maize starch Magnesium hydroxide Polacrilin potassium Polyethylene glycol 8000 Polyethylene glycol 400 Hydroxypropyl methyl cellulose Sorbic acid

Pack sizes and marketing

High density Polyethylene bottle with urea cap with 100 tablets, securitainer or snap-secure container with 50, 100 or 1000 tablets.

Blister packs containing 10, 14, 15, 28 or 56 tablets: PVC, heat sealed with 20 micron hard tamper aluminium foil.

Marketing authorization holder

Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK

Marketing authorization dates and numbers

PL 20072/0036

16/01/2006

Drugs

Drug	Countries
ERYTHROCIN	Canada, Ireland, Japan, Malta, South Africa

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.